Thisisengineering Raeng Jzdrzzz50ta Unsplash

Advanz Pharma

Specialty Pharmaceuticals

ADVANZ PHARMA is a UK-headquartered pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe and Canada that is comitted to improve the lives of patients by providing and enhancing the medicines they depend on.

Company Background

  • Agile and experienced team, including direct sales, marketing and medical capability across many of Europe’s major markets and a global distribution network
  • Broad expertise in several therapeutic areas with particular strengths in the critical care, anti-infectives, endocrinology, cardiovascular and more broadly on rare disease medicines, particularly in hepatology and gastroenterology

Vision & Outlook

Further grow the position as a partner of choice for specialty and hospital pharmaceuticals in Europe and beyond.

Invest in a strengthened platform to accelerate the company’s pipeline of innovative specialty pharmaceutical products.

Highlights & Updates

Aquisition of the majority of Intercept Pharmaceutical's subsidiaries and operations in Europe, Canada, and all other markets outside of the U.S in 2022.

Combination more than doubles ADVANZ PHARMA’s commercial and medical team with sizable additions across major EU countries.

Advanz Pharma

SECTOR

Healthcare

REVENUES 2021

EUR 510 million

EMPLOYEES

555

OWNERSHIP

Fund X

HEAD OFFICE

UK

INVESTMENT DATE

2021

MANAGEMENT

Steffen Wagner

CEO

Andreas Stickler

CFO

RESPONSIBLE ADVISORS

Raj Shah

Partner | Head of Healthcare

Rainer Lenhard

Partner | Co-Head of DACH